Mountain View, California, April 11, 2022 – Crosscope Inc. a leading provider of AI-enabled digital pathology software and Waleed Pharmacy & Stores LLC an Omar Zawawi Establishment (OMZEST) group company focused on bringing healthcare,...

aetherAI Machine Learning Approach for Classification of Primary Intestinal T-Cell Lymphomas Published in Cancers TAIPEI, TAIWAN, April 6, 2022 /EINPresswire.com/ -- aetherAI—Asia’s leading medical image AI solution provider focused on...

Proscia and Visiopharm: Partnership to improve clinical decision making for breast and colon cancer care HOERSHOLM, Denmark & PHILADELPHIA – March 22, 2022 – Proscia®, a leader in digital and computational pathology solutions, and...

Milan, March 10th, 2022 – Dedalus Group ("Dedalus"), the leading healthcare and diagnostic software solutions provider in Europe, and Ibex Medical Analytics (“Ibex”), the market leader in artificial intelligence (AI)-powered cancer...

Visiopharm has announced preregistration for their USCAP 2022 seminar. AI-driven stain quality standardization of IHC Featuring Marilyn M. Bui, MD, Ph.D., Moffitt Cancer Center and Martin Kristensson, Visiopharm Wednesday, March 23rd,...

HOUSTON, Texas — An implantable “drug factory” the size of a pinhead could cure a patient’s cancer in less than a week! Those are the findings of a new study by bioengineers at Rice University who say the new treatment can completely...